GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IXICO PLC (FRA:PYPB) » Definitions » Equity-to-Asset

IXICO (FRA:PYPB) Equity-to-Asset : 0.85 (As of Sep. 2024)


View and export this data going back to . Start your Free Trial

What is IXICO Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. IXICO's Total Stockholders Equity for the quarter that ended in Sep. 2024 was €11.28 Mil. IXICO's Total Assets for the quarter that ended in Sep. 2024 was €13.33 Mil. Therefore, IXICO's Equity to Asset Ratio for the quarter that ended in Sep. 2024 was 0.85.

The historical rank and industry rank for IXICO's Equity-to-Asset or its related term are showing as below:

FRA:PYPB' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.6   Med: 0.76   Max: 0.88
Current: 0.85

During the past 13 years, the highest Equity to Asset Ratio of IXICO was 0.88. The lowest was 0.60. And the median was 0.76.

FRA:PYPB's Equity-to-Asset is ranked better than
74.54% of 1512 companies
in the Biotechnology industry
Industry Median: 0.67 vs FRA:PYPB: 0.85

IXICO Equity-to-Asset Historical Data

The historical data trend for IXICO's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IXICO Equity-to-Asset Chart

IXICO Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.77 0.81 0.85 0.88 0.85

IXICO Semi-Annual Data
Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.85 0.86 0.88 0.87 0.85

Competitive Comparison of IXICO's Equity-to-Asset

For the Biotechnology subindustry, IXICO's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IXICO's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, IXICO's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where IXICO's Equity-to-Asset falls into.



IXICO Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

IXICO's Equity to Asset Ratio for the fiscal year that ended in Sep. 2024 is calculated as

Equity to Asset (A: Sep. 2024 )=Total Stockholders Equity/Total Assets
=11.279/13.334
=0.85

IXICO's Equity to Asset Ratio for the quarter that ended in Sep. 2024 is calculated as

Equity to Asset (Q: Sep. 2024 )=Total Stockholders Equity/Total Assets
=11.279/13.334
=0.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IXICO  (FRA:PYPB) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


IXICO Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of IXICO's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


IXICO Business Description

Traded in Other Exchanges
Address
15 Long Lane, 4th Floor, Griffin Court, London, GBR, EC1A 9PN
IXICO PLC is a UK-based company engaged in providing clinical trial services and technology to evaluate imaging endpoints to pharmaceutical companies. Its therapeutic areas include Alzheimer's, Parkinson's, Huntington's, Multiple Sclerosis, Progressive Supranuclear Palsy, and Other Rare Neurological Diseases. Services offered by the company are Early Phase Clinical Development, Late Phase Clinical Development, Post-Marketing, and Consultancy. The company's geographical segments include the United States, Switzerland, the United Kingdom, the Netherlands, Ireland and other- Europe. The Company work with healthcare organizations across the entire clinical research journey, for drug development analytics, medical imaging operations and post-marketing surveillance.

IXICO Headlines

No Headlines